FDA
- Status: approved
colloidal bismuth sub-citrate (colloidal bismuth sub-citrate) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Queen Fabiola Children's University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.